Return to study ST001868 main page

MB Sample ID: SA174639

Local Sample ID:1356_L
Subject ID:SU001945
Subject Type:Mammal
Subject Species:Ovis aries
Taxonomy ID:9940
Animal Inclusion Criteria:Pregnant

Select appropriate tab below to view additional metadata details:


Subject:

Subject ID:SU001945
Subject Type:Mammal
Subject Species:Ovis aries
Taxonomy ID:9940
Animal Inclusion Criteria:Pregnant

Factors:

Local Sample IDMB Sample IDFactor Level IDLevel ValueFactor Name
1356_LSA174639FL021449ControlCortisol treatment
1356_LSA174639FL021449DCA-treated (over 24h)DCA treatment

Collection:

Collection ID:CO001938
Collection Summary:Heart tissue was collected from the right ventricle, left ventricle, and intraventricular septum and immediately frozen in liquid nitrogen.
Sample Type:Heart
Storage Conditions:-80℃

Treatment:

Treatment ID:TR001957
Treatment Summary:Animals in the CORT and CORT+DCA groups were implanted with pellets of cortisol hemisuccinate (Innovative Research, Sarasota, FL) or infused with cortisol hemisuccinate (Solu-Cortef, Pfizer, Inc) using an ambulatory pump (3D Micro Infusion Pump; Strategic Applications Inc.; Lake Villa, IL) to provide dosing of cortisol at 1mg/kg/day beginning on day 115-116 of gestation until the end of the experiment when the animals were sacrificed. This dose of cortisol increased maternal cortisol concentrations to approximately 1.5-fold, mimicking the rise in cortisol in moderate stress. To produce a regular pattern of labor, ewes were infused with oxytocin (Aspen Veterinary Resources) beginning at day 138-140 of gestation; oxytocin was infused over 5 minutes every 30 minutes (820 µU/kg/min iv;) using an infusion pump controlled by a timed controller ChronTrol Corp, Inc). DCA infusion was started 48 hours after the start of oxytocin. DCA was administered as an intravenous bolus of 25 mg/kg over 3 minutes, followed by an infusion of 12.5 mg DCA/kg/hour for 8 hours, and an infusion of 6.25 mg DCA/kg/h for the next 8 hours. These doses are similar to those that significantly decrease circulating lactate concentrations in humans. The timed infusions of oxytocin continued for 72 hours, and the study was terminated after 24 hours of DCA and/or 72 hours of oxytocin infusion, unless ewes were in the process of delivery or birth occurred.

Sample Preparation:

Sampleprep ID:SP001951
Sampleprep Summary:Heart tissues were cut to ~ 30 mg and weighted. Each tissue was added to 30 µl of D2O with 10/3 mM sodium trimethylsilylpropane-sulfonate (DSS) and transferred to a 4-mm zirconium dioxide rotor with Kel-F cap and PTFE spacer provided by Bruker Biospin. Samples were kept on dry ice during sample preparation.
Sampleprep Protocol Filename:SamplePrepProtocol.pdf

Analysis:

MB Sample ID:SA174639
Analysis ID:AN003030
Laboratory Name:Edison Lab
Analysis Type:NMR
Software Version:Topspin 4.0.6
Results File:Noesy_binned_data.txt UNITS:(relative)

NMR:

NMR ID:NM000209
Analysis ID:AN003030
Instrument Name:Bruker NEO 600MHz
Instrument Type:FT-NMR
NMR Experiment Type:1D-1H
Field Frequency Lock:D2O
Spectrometer Frequency:600 MHz
NMR Probe:4mm CMP_HRMAS
NMR Solvent:D2O
NMR Tube Size:50 ul
Shimming Method:manual
Pulse Sequence:noesypr1d
Water Suppression:presat
Receiver Gain:101
Chemical Shift Ref Cpd:DSS
Temperature:10
Number Of Scans:128
Dummy Scans:8
Acquisition Time:1.70 s
Spectral Width:16.0240 ppm
Num Data Points Acquired:32768
Line Broadening:1.8 Hz
Baseline Correction Method:ABSG
NMR Results File:Noesy_binned_data.txt UNITS:(relative)
  logo